– USA, GA – True Nature Holding, Inc. (OTCQB:TNTY), announces the appointment of Ronald Riewold as Chairman of its Board of Directors.
“The Company is entering a phase of rapid growth and we need a team that can execute on day one. Ron has both NASDAQ and AMEX company senior management experience, which is key as we position TNTY for an uplist. In health care, he knows at the field-level what the market needs and how to effectively communicate our vision. He is a perfect fit for where we are and more importantly where we want to go,” said True Nature’s President, Jim Crone. “We’ve made it a priority to bring together a team of very accomplished and experienced professionals. We will be making further announcements shortly and expect to have a full slate of well-qualified directors on our Board. We also have an Advisory Board and will continue to add subject matter expertise to assist the Company through these appointments.”
About Ron Riewold
Mr. Riewold contributes extensive senior leadership experience in managing, operating, and growing both public and private companies. Mr. Riewold has been a top executive of six companies since 1978, including three in the health care and technology sectors.
Mr. Riewold brings over 35-years of experience as a corporate and entrepreneurial leader in the finance, technology, and health care markets. He has served as Vice President of Corporate Development, COO, President, CEO of organizations including Heart Labs of America, Cyber Care, Pain Care Holdings, and Averlent Corporation – a recently formed group focused on telehealth solutions at the local level.
Mr. Riewold commented, “In my view, the public-company platform that TNTY provides could accelerate the growth of early development organizations that need access to capital relatively quickly. We have a team looking for acquisition opportunities to fuel the growth of TNTY working with developing companies in the health care information technology market space. I’m looking forward to collaborating with the management team to help ensure continued success.”
Mr. Riewold earned a bachelor’s degree from Florida State University in 1970, and a Master of Business Administration from Temple University, 1979.
True Nature Holding, Inc.
To leverage new technologies and services to improve healthcare and outcome for individuals, their families, and their pets. We believe we can reduce the cost of healthcare while improving the quality of life using Telehealth and Telemedicine Solutions.
We are building healthcare applications that focus on patient engagement, care coordination, remote monitoring, data analytics, and may include Blockchain RX™ to provide applications for market participants in healthcare through the encryption of sensitive data.
Our approach is to develop these business opportunities as individual “threads” in response to client needs, ultimately creating an end-to-end set of solutions from the end user up to the healthcare provider, or veterinary professional. Further, we expect to assist suppliers to the healthcare industry by allowing them to access unique technologies that bind them with their clients in a “top-down” distribution model.
We recognize it will take the investment of major market participants like Apple, Amazon, IBM, hospitals, healthcare networks, pharmacy and other providers for us to achieve critical mass. In consideration of this reality, we expect to work with these market makers in collaboration, and in support of the ultimate user, the individual, and their pets. The day of “direct-to-consumer” healthcare, including “the humanization of our pets” is upon us, and we hope to be key parties to their evolution, and success.
For more information : https://www.truenaturepharma.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
